Advertisement

Herzfrequenzreduktion — ein wichtiger Mechanismus für eine günstige Beeinflussung der Prognose

  • J. Kjekshus

Zusammenfassung

Die Herzfrequenz ist ein prognostischer Index des kardiovaskulären Risikos vor, während und nach einem koronaren Ereignis [1,2,3]. Nach einem akuten Myokardinfarkt beträgt das Risikoverhältnis fär Patienten mit einer Herzfrequenz äber 90 Schlägen pro Minute bezogen auf Patienten mit einer Herzfrequenz unter 60 Schlägen pro Minute 2,7, und das Risiko steigt bei über 110 Schlägen pro Minute deutlich an.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Kannel WB, Kannel C, Paffenbarger RS, Adrenne PH, Adrenne L (1987) Heart rate and cardiovascular mortality: The Framingham Study, Am Heart J 113: 1489–1494.PubMedCrossRefGoogle Scholar
  2. 2.
    Hjalmarson Å, Gilpin E, Kjekshus J, Scheiman G, Nicod P, Henning H, Ross J (1990) Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol, March 1: 547–553.CrossRefGoogle Scholar
  3. 3.
    Dyer AR, Persky V, Stampler J et al. (1980) Heart rate as a prognostic factor for coronary heart disease and mortality: Findings in three Chicago epidemiologic studies. Am J Epidemiol 112: 736–749.PubMedGoogle Scholar
  4. 4.
    Moser DK, Stevenso WG, Woo MA, Stevenson LW (1994) Timing of sudden death in patients with heart failure. J Am Coll Cardiol 24: 963–7.PubMedCrossRefGoogle Scholar
  5. 5.
    ISIS-2 collaborative group (1992) Morning peak in the incidence of myocardial infarction: experience in the ISIS-2 trial. Eur Heart J 13: 594–598.Google Scholar
  6. 6.
    Sandvik L, Erikssen J, Ellestad M, Erikssen G, Thaulow E, Mundial R, Rodahl K (1995) Heart rate increase and maximal heart rate during exercise as predictors of cardiovascular mortality: a 16-year follow-up study of 1960 healthy men. Coron Art Dis 1995; 6: 667–679.CrossRefGoogle Scholar
  7. 7.
    Cripps TR (1991) Prognostic value of reduced heart rate varibility after myocardial infarction in clinical evaluation of a new analysis method. Br Heart J 65: 1449.CrossRefGoogle Scholar
  8. 8.
    Beere PA, Glasgow S, Zarins CK 1984 Retarding effect of lowered heart rate on coronary atherosclerosis. Science 226: 180–182.PubMedCrossRefGoogle Scholar
  9. 9.
    Williams PT, Haskell WL, Vranizan KM et al. (1985) Associations of resting heart rate with concentrations of lipoprotein subfractions in sedentary men. Circulation 1985; 71: 441–449.PubMedCrossRefGoogle Scholar
  10. 10.
    Brown BG, Zhao X-Q, Sacco DE et al. (1993) Lipid-lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary disease. Circulation 87: 1781–91.PubMedGoogle Scholar
  11. 11.
    Bristow MR, Lowes BD 1994 Low dose inotropic therapy for ambulatory heart failure. Coronary Artery Dis 5: 112–8.CrossRefGoogle Scholar
  12. 12.
    Kjekshus J (1986) Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol 57: 43f–49f.PubMedCrossRefGoogle Scholar
  13. 13.
    Noda T, Arakawa M, Miwa H et al. (1996) Effects of heart rate on flow velocity of the left atrial appendage in patients with nonvalvular atrial fibrillation. Clin Cardiol 19: 295–300.PubMedCrossRefGoogle Scholar
  14. 14.
    Kjekshus J, Schytte-Blix A, Eisner R, Hoi R, Amundsen E (1982) Myocardial blood flow and metabolism in the diving seal. Am J Physiol 242: 97–104.Google Scholar
  15. 15.
    Eisner R, Millard RW, Kjekshus JK, White F, Blix AS, Kemper S (1985) Coronary blood flow and myocardial segment dimensions during simulated dives in seals. Am J Physiol 249: 1119–1126.Google Scholar
  16. 16.
    Kjekshus JK, Blix AS, Grøttum P, Aasen AO (1981) Beneficial effects of vagal stimulation on the ischaemic myocardium during beta-receptor blockade. Scand J Clin Lab Invest; 41: 383–389.PubMedCrossRefGoogle Scholar
  17. 17.
    Simonsen S, Ihlen J, Kjekshus JK (1983) Haemodynamic and metabolic effects of timolol (blocadren) on ischaemic myocardium. Acta Med Scand 213: 393–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Boudoulas H, Rittgers E, Lewis RP, Leier CV, Weissler A (1979) Changes in diastolic time with various pharmacologic agents. Circulation 60: 164–169.PubMedGoogle Scholar
  19. 19.
    Domench RJ, La Prida JM de (1975) Mechanical effects of heart contraction on coronary flow. Cardiovasc Res 9: 509–514.CrossRefGoogle Scholar
  20. 20.
    Niemela MJ, Airakasinen KEJ, Huikuri H (1994) Effect of beta-blockade on heart rate variability in patients with coronary artery disease. J Am Coll Cardiol 6: 1370–1377.CrossRefGoogle Scholar
  21. 21.
    Mjøs OD, Kjekshus J, Lekven J (1974) Importance of free fatty acids as a determinant of myocardial oxygen consumption and myocardial ischemic injury during norepinephrine infusion in dogs. J Clin Invest 53: 1290–1299.PubMedCrossRefGoogle Scholar
  22. 22.
    Sugiyama S, Hattori M, Miyazaki Y, Nagai S, Ozawa T (1985) Mechanism of antiarrhythmic action of beta-blocking agents. J Electrocardiology 18 (2): 169–174.CrossRefGoogle Scholar
  23. 23.
    International Collaborative Study Group (1984) Reduction in infarct size with the early use of timolol in acute myocardial infarction. N Engl J Med; 310: 9–15.CrossRefGoogle Scholar
  24. 24.
    Shell WE, Sobel BE (1973) Deleterious effects of increased heart rate on infarct size in the conscious dog. Am J Cardiol 31: 474–79.PubMedCrossRefGoogle Scholar
  25. 25.
    Sirnes PA, Overskeid K, Pedersen T et al. (1984) Evolution of infarct size during the early use of nifedipine in patients with acute myocardial infarction: The Norwegian Nifedipine Multicenter Trial. Circulation 70: 638–644.PubMedCrossRefGoogle Scholar
  26. 26.
    The Danish Study Group on Verapamil in Myocardial Infarction (1990) Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish verapamil infarction trial II-DAVIT II). Am J Cardiol 66: 779–885.CrossRefGoogle Scholar
  27. 27.
    Kailasam MT, Parmer RJ, Cervenka JH et al. (1995) Divergent effects of dihydropyridine and phenylalkylamine calcium channel antagonist classes on autonomic function in human hypertension. Hypertension 26: 143–149.PubMedGoogle Scholar
  28. 28.
    ISIS I (First International Study of Infarct Survival) Collaborative Group (1986) Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS - I. Lancet 2: 57–66.Google Scholar
  29. 29.
    The MIAMI Trial Research Group (1985) Metoprolol in acute myocardial infarction (MIAMI): A randomised placebo-controlled international trial. Eur Heart J 6: 199–226.Google Scholar
  30. 30.
    Roberts R, Rogers WJ, Mueller HS et al. (1991) Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Circulation 2: 422–437.Google Scholar
  31. 31.
    Gundersen T, Grøttum P, Pedersen T, Kjekshus K (1986) Effect of timolol on mortality and reinfarction after myocardial infarction: prognostic importance of heart rate at rest. Am J Cardiol 58: 20–24.PubMedCrossRefGoogle Scholar
  32. 32.
    Yusuf S, Lewis PR, Collins R, Sleight P (1985) Beta blockade during and after myocardial infarction. An overview of the randomized trials. Prog Cardiovasc Dis 27: 335–371.Google Scholar
  33. 33.
    Forfang K, Gullestad L (1995) Medical treatment of angina pectoris - Are the possibilities exploited well enough? Tidsskr Nor Laegeforen 115: 2264–7.PubMedGoogle Scholar
  34. 34.
    Gullestad L, Kjekshus J (1992) Heart disease in diabetes mellitus. Tidsskr Nor Laegeforen 1992; 112: 1016–19.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • J. Kjekshus

There are no affiliations available

Personalised recommendations